[Health care associated multidrug-resistant bacteria in a pediatric hospital: five year experience]

Patrícia Mação1, João Casalta Lopes, Henrique Oliveira

  • 1Unidade de Infecciologia. Hospital Pediátrico. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.. patriciamacao@gmail.com.

Acta Medica Portuguesa
|September 11, 2013
PubMed

Insights

Multidrug-resistant bacteria infections in children increased in proportion but remained stable in incidence. Methicillin-resistant Staphylococcus aureus (MRSA) was the most common pathogen, with bloodstream infections being most frequent.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Paediatric Healthcare

Context:

  • Rising global concern over multidrug-resistant bacteria (MDRB).
  • Limited paediatric data available, especially at national levels.
  • Focus on healthcare-associated infections (HAIs) in a specialized paediatric setting.

Purpose:

  • To analyze trends in healthcare-associated multidrug-resistant bacteria infections within a paediatric hospital.
  • To identify the most prevalent MDRB and infection types in children.
  • To assess the incidence and risk factors associated with paediatric MDRB infections.

Summary:

  • A retrospective study (2005-2009) in a level III paediatric hospital identified 106 MDRB events in 72 children.
  • Methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant Pseudomonas aeruginosa (PA-MDR), and ESBL-producing bacilli were most common.
  • While the proportion of MDRB increased, the overall incidence rate remained stable at 0.400 per 1000 hospitalization-days. Bloodstream infections were most frequent.

Impact:

  • Highlights the persistent challenge of MDRB in paediatric populations.
  • Informs targeted infection control strategies in paediatric hospitals.
  • Emphasizes the importance of considering risk factors like prior antibiotic use and chronic conditions in paediatric patients.
Abstract

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...